BiotechTube
Home/Dr. Reddy's Laboratories/Erez Israeli
EI

Erez Israeli

CEO - North America Generics & Global Head of API business

Dr. Reddy's Laboratories

Therapeutic Areas

OncologyCardiovascularDiabetesInfectious DiseasesGastroenterologyNeurologyImmunology

Dr. Reddy's Laboratories Pipeline

DrugIndicationPhase
Lenalidomide (Generic Revlimid)Multiple MyelomaApproved
Esomeprazole (Generic Nexium)GERDApproved
Glatiramer Acetate (Generic Copaxone)Multiple SclerosisApproved
Rituximab BiosimilarOncology/AutoimmuneApproved
Trastuzumab BiosimilarBreast CancerApproved
Pegfilgrastim BiosimilarNeutropeniaApproved
DRL-17822OncologyPhase 2

Leadership Team at Dr. Reddy's Laboratories

GP
G.V. Prasad
Vice Chairman & CEO
PA
Parag Agarwal
CFO
MN
M.V. Narasimham
CEO - Emerging Markets & India
DS
Deepak Sapra
CEO - API & Services
RG
Richa Gangopadhyay
Chief Human Resources Officer
View full Dr. Reddy's Laboratories profile